{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/peripheral-arterial-disease/background-information/risk-factors/","result":{"pageContext":{"chapter":{"id":"ea6fdfd8-a5f7-52de-ac19-8a05fd53556f","slug":"risk-factors","fullItemName":"Risk factors","depth":2,"htmlHeader":"<!-- begin field 779234b0-987c-4e86-ab2b-4c4d7a902ae0 --><h2>What are the risk factors?</h2><!-- end field 779234b0-987c-4e86-ab2b-4c4d7a902ae0 -->","summary":"","htmlStringContent":"<!-- begin item 8c69c4f2-568e-4139-972e-4bc5283ce82d --><!-- begin field 2296d85b-0fee-41c5-af99-3a98580e48d3 --><ul><li><strong>Risk factors for peripheral arterial disease are typical of those predisposing to other cardiovascular diseases, with smoking and diabetes mellitus being the strongest </strong>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/peripheral-arterial-disease/references/\">Conte et al, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/peripheral-arterial-disease/references/\">Criqui and Aboyans, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/peripheral-arterial-disease/references/\">Foley et al, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/peripheral-arterial-disease/references/\">Kullo and Rooke, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/peripheral-arterial-disease/references/\">Aboyans et al, 2018</a>]:  <ul><li><strong>Smoking</strong> has been shown to be one of the strongest risk factors for peripheral arterial disease. Smoking at least doubles the odds of peripheral arterial disease compared with not smoking and heavier smokers are at increased risk compared with light smokers. People with peripheral arterial disease who continue to smoke are at increased risk of developing claudication and critical limb ischaemia and are twice as likely to need limb amputation compared with someone who quits.</li><li><strong>Diabetes mellitus</strong> is strongly associated with an increased risk of peripheral arterial disease, especially in people with more severe, poorly controlled, or longstanding diabetes. Evidence suggests outcomes of peripheral arterial disease (such as amputation rates and mortality) are worse in people with diabetes. </li></ul></li><li><strong>Other risk factors for peripheral arterial disease include</strong> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/peripheral-arterial-disease/references/\">Conte et al, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/peripheral-arterial-disease/references/\">Criqui and Aboyans, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/peripheral-arterial-disease/references/\">Kullo and Rooke, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/peripheral-arterial-disease/references/\">Morley et al, 2018</a>]  [<a class=\"bibliography-reference internal-reference\" href=\"/topics/peripheral-arterial-disease/references/\">Firnhaber and Powell, 2019</a>]: <ul><li>Advanced age.</li><li>Hypertension — studies have indicated an association between hypertension and peripheral arterial disease.</li><li>Hypercholesterolaemia — total cholesterol has been found to be significantly associated with peripheral arterial disease.</li><li>Known atherosclerotic disease elsewhere (for example coronary, carotid, abdominal aorta).</li><li>Chronic kidney disease —<strong> </strong>an association has been seen in several studies, particularly in people with end-stage renal disease needing dialysis.</li><li>High serum homocysteine — may be an independent risk factor for peripheral arterial disease, but there have been conflicting results between studies.</li><li>The odds of having peripheral arterial disease increase with higher numbers of risk factors. One risk factor gives a 1.5-fold increase, three or more risk factors give a 10-fold increase [<a class=\"bibliography-reference internal-reference\" href=\"/topics/peripheral-arterial-disease/references/\">Firnhaber and Powell, 2019</a>].</li></ul></li><li><strong>Not all people with <em>acute </em>limb ischaemia have risk factors </strong>(for example atrial fibrillation, smoking, or diabetes)<strong> </strong>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/peripheral-arterial-disease/references/\">Brearley, 2013</a>].</li></ul><!-- end field 2296d85b-0fee-41c5-af99-3a98580e48d3 --><!-- end item 8c69c4f2-568e-4139-972e-4bc5283ce82d -->","topic":{"id":"fff7e03a-2313-5ab5-b744-9c6bba67aa6b","topicId":"deeaf796-d620-42bf-903e-a43ff99b1d1d","topicName":"Peripheral arterial disease","slug":"peripheral-arterial-disease","lastRevised":"Last revised in September 2019","chapters":[{"id":"9e988871-ea98-52a6-bb9d-910e22b3a6dd","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"81e6bfaf-7c78-52e2-b11d-8e2315ebe9e4","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"fee65eb3-86d0-571b-9815-f9407ec29fa7","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"239ddbef-73a4-5941-9dc8-52d73689e140","slug":"changes","fullItemName":"Changes"},{"id":"39825e21-a7b7-573c-86a7-fd5d87a847d3","slug":"update","fullItemName":"Update"}]},{"id":"da348d6d-4102-5de5-b9be-d28e7c83e8d0","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"c0f3f64c-323d-5c10-b5ff-9df793eab0d8","slug":"goals","fullItemName":"Goals"},{"id":"504b7741-50ac-5c4c-ac51-ea56d8cc4c46","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"a7e09ccb-6701-5658-a01c-52a02d7f9f80","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"a54b63f6-0b42-5584-91e8-027e613f7246","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"f6168c43-2e36-5e1d-bb44-04674d098b73","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"67399dd0-adb5-5b36-a616-cfc0605ebe52","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"9c30093e-b7fa-5c0f-84d0-465bf0768823","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"8f766fdc-ff98-5227-9d99-fe65802aaaca","slug":"definition","fullItemName":"Definition"},{"id":"4c33be40-568c-527a-8936-a79726b11e66","slug":"causes","fullItemName":"Causes"},{"id":"b8817533-a2e9-531b-9c51-d1c3da17b2ef","slug":"prevalence","fullItemName":"Prevalence"},{"id":"ea6fdfd8-a5f7-52de-ac19-8a05fd53556f","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"cdbbc165-3643-5f50-8f32-9fc5504ba2ef","slug":"complications","fullItemName":"Complications"},{"id":"59787aa9-8de0-5efd-b54e-2d72c75845a5","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"59e978dc-e4bc-574d-a047-413f87ec6b3d","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"ea4a531c-cf38-5e54-85d9-1f845bf7582f","slug":"when-to-suspect","fullItemName":"When to suspect"},{"id":"ebe23574-b6e5-5812-816c-6955392cee34","slug":"assessment","fullItemName":"Assessment"},{"id":"c501646c-c9a8-5372-ae9c-c0aab453c6e5","slug":"features-of-acute-limb-ischaemia","fullItemName":"Features of acute limb ischaemia"},{"id":"fdc33cb6-26a1-58c3-8eab-79d69745d871","slug":"features-of-intermittent-claudication-critical-limb-ischaemia","fullItemName":"Features of intermittent claudication and critical limb ischaemia"},{"id":"8c98aa45-6aef-5b47-a997-e9eeec827356","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"04fcdfca-c3cb-56b4-a18e-535c5a54e1a9","fullItemName":"Management","slug":"management","subChapters":[{"id":"fb3fcf0a-56a8-5693-b5ef-75e12c6f1f11","slug":"acute-limb-ischaemia","fullItemName":"Scenario: Acute limb ischaemia"},{"id":"d89d9e21-f892-533e-a3b8-e5649a205398","slug":"critical-limb-ischaemia","fullItemName":"Scenario: Critical limb ischaemia"},{"id":"357ee79f-9fa4-57e7-abd7-7881201f1629","slug":"intermittent-claudication","fullItemName":"Scenario: Intermittent claudication"}]},{"id":"da28584d-59b4-5a06-9357-9484a9bf93cc","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"e3ab00c1-43b9-58c7-a1c4-44198627e4ab","slug":"naftidrofuryl-oxalate","fullItemName":"Naftidrofuryl oxalate"},{"id":"bb79b6c3-de22-58b3-9244-5ae82a6133ad","slug":"paracetamol-weak-opioids","fullItemName":"Paracetamol and weak opioids"}]},{"id":"1545d985-832b-5a4a-abc9-bd7f0c21b754","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"049d6682-f78d-5c05-bdfb-1dbd5e91b017","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"58d7e6c5-f97f-507d-b627-87ab85bde479","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"574b8e96-33b9-5191-81dd-f415c704abf9","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"f3df8039-73c2-5c30-b7e8-2566977e32dc","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"d466274b-a2ab-58f1-badc-abfed7066e4f","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"aaed3513-3a59-5991-8410-2c4446539abd","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"74346084-c291-5a06-ac3d-a0ae85243940","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"9c30093e-b7fa-5c0f-84d0-465bf0768823","slug":"background-information","fullItemName":"Background information"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}